28109317|t|Sorting nexin-4 regulates β-amyloid production by modulating β-site-activating cleavage enzyme-1
28109317|a|Amyloid precursor protein (APP) is cleaved by β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) to produce β-amyloid (Aβ), a critical pathogenic peptide in Alzheimer's disease (AD). Aβ generation can be affected by the intracellular trafficking of APP or its related secretases, which is thus important to understanding its pathological alterations. Although sorting nexin (SNX) family proteins regulate this trafficking, the relevance and role of sorting nexin-4 (SNX4) regarding AD has not been studied yet. In this study, human brain tissue and APP / PS1 mouse brain tissue were used to check the disease relevance of SNX4. To investigate the role of SNX4 in AD pathogenesis, several experiments were done, such as coimmunoprecipitation, Western blotting, immunohistochemistry, and gradient fractionation. We found that SNX4 protein levels changed in the brains of patients with AD and of AD model mice. Overexpression of SNX4 significantly increased the levels of BACE1 and Aβ. Downregulation of SNX4 had the opposite effect. SNX4 interacts with BACE1 and prevents BACE1 trafficking to the lysosomal degradation system, resulting in an increased half-life of BACE1 and increased production of Aβ. We show that SNX4 regulates BACE1 trafficking. Our findings suggest novel therapeutic implications of modulating SNX4 to regulate BACE1 -mediated β-processing of APP and subsequent Aβ generation.
28109317	0	15	Sorting nexin-4	T116,T123	C1739732
28109317	26	35	β-amyloid	T116	C3484390
28109317	36	46	production	T044	C1510880
28109317	50	60	modulating	T082	C0443264
28109317	61	96	β-site-activating cleavage enzyme-1	T116,T126	C1569775
28109317	97	122	Amyloid precursor protein	T116	C0085151
28109317	124	127	APP	T116	C0085151
28109317	143	193	β-site amyloid precursor protein-cleaving enzyme 1	T116,T126	C1569775
28109317	195	200	BACE1	T116,T126	C1569775
28109317	213	222	β-amyloid	T116	C3484390
28109317	224	226	Aβ	T116	C3484390
28109317	240	250	pathogenic	T033	C3816499
28109317	251	258	peptide	T116	C0030956
28109317	262	281	Alzheimer's disease	T047	C0002395
28109317	283	285	AD	T047	C0002395
28109317	288	290	Aβ	T116	C3484390
28109317	291	301	generation	T044	C1510880
28109317	325	350	intracellular trafficking	T044	C1513112
28109317	354	357	APP	T116	C0085151
28109317	373	383	secretases	T116,T126	C0171484
28109317	430	454	pathological alterations	T169	C1521733
28109317	465	500	sorting nexin (SNX) family proteins	T116,T123	C2936363
28109317	515	526	trafficking	T044	C1513112
28109317	554	569	sorting nexin-4	T116,T123	C1739732
28109317	571	575	SNX4	T116,T123	C1739732
28109317	587	589	AD	T047	C0002395
28109317	631	636	human	T016	C0086418
28109317	637	649	brain tissue	T023	C0459385
28109317	654	657	APP	T116	C0085151
28109317	660	663	PS1	T116,T123	C0299212
28109317	664	669	mouse	T015	C0025929
28109317	670	682	brain tissue	T023	C0459385
28109317	706	713	disease	T047	C0012634
28109317	727	731	SNX4	T116,T123	C1739732
28109317	760	764	SNX4	T116,T123	C1739732
28109317	768	770	AD	T047	C0002395
28109317	771	783	pathogenesis	T046	C0699748
28109317	793	804	experiments	T062	C0681814
28109317	824	845	coimmunoprecipitation	T059	C1449705
28109317	847	863	Western blotting	T059,T063	C0005863
28109317	865	885	immunohistochemistry	T060	C0021044
28109317	891	913	gradient fractionation	T059	C0007704
28109317	929	933	SNX4	T116,T123	C1739732
28109317	934	948	protein levels	T034	C0428479
28109317	964	970	brains	T023	C0006104
28109317	974	982	patients	T101	C0030705
28109317	988	990	AD	T047	C0002395
28109317	998	1000	AD	T047	C0002395
28109317	1001	1011	model mice	T015	C0025929
28109317	1013	1027	Overexpression	T045	C1514559
28109317	1031	1035	SNX4	T116,T123	C1739732
28109317	1074	1079	BACE1	T116,T126	C1569775
28109317	1084	1086	Aβ	T116	C3484390
28109317	1088	1102	Downregulation	T044	C0013081
28109317	1106	1110	SNX4	T116,T123	C1739732
28109317	1136	1140	SNX4	T116,T123	C1739732
28109317	1156	1161	BACE1	T116,T126	C1569775
28109317	1175	1180	BACE1	T116,T126	C1569775
28109317	1181	1192	trafficking	T044	C1513112
28109317	1200	1209	lysosomal	T029	C0521450
28109317	1210	1228	degradation system	T040	C0699900
28109317	1256	1265	half-life	T079	C0018517
28109317	1269	1274	BACE1	T116,T126	C1569775
28109317	1289	1299	production	T044	C1510880
28109317	1303	1305	Aβ	T116	C3484390
28109317	1320	1324	SNX4	T116,T123	C1739732
28109317	1335	1340	BACE1	T116,T126	C1569775
28109317	1341	1352	trafficking	T044	C1513112
28109317	1381	1392	therapeutic	T169	C0302350
28109317	1409	1419	modulating	T082	C0443264
28109317	1420	1424	SNX4	T116,T123	C1739732
28109317	1437	1442	BACE1	T116,T126	C1569775
28109317	1453	1465	β-processing	T052	C1709694
28109317	1469	1472	APP	T116	C0085151
28109317	1488	1490	Aβ	T116	C3484390
28109317	1491	1501	generation	T044	C1510880